Novartis Ag Adr Stock Analysis

Novartis Stock Analysis Notes

The book value of the company was now reported as 22.83. The company last dividend was issued on the 7th of March 2024. Novartis AG ADR had 1116:1000 split on the 9th of April 2019. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 108000 people. To find out more about Novartis AG ADR contact Chris Ilsley at 41 61 324 1111 or learn more at https://www.novartis.com.

Novartis AG ADR Investment Alerts

Novartis AG ADR Upcoming and Recent Events

Novartis Largest EPS Surprises

View All Earnings Estimates

Novartis Thematic Classifications

Novartis Stock Institutional Investors

Note, although Novartis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Novartis Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 190.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novartis's market, we take the total number of its shares issued and multiply it by Novartis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novartis Profitablity

The company has Net Profit Margin of 0.32 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.25 %, which entails that for every 100 dollars of revenue, it generated $0.25 of operating income.

Management Efficiency

Novartis AG ADR has Return on Asset of 0.0727 % which means that on every $100 spent on assets, it made $0.0727 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1615 %, implying that it generated $0.1615 on every 100 dollars invested. Novartis' management efficiency ratios could be used to measure how well Novartis manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Novartis' Return On Tangible Assets are comparatively stable compared to the past year. Return On Capital Employed is likely to gain to 0.14 in 2024, whereas Return On Assets are likely to drop 0.11 in 2024. At this time, Novartis' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 73.2 B in 2024, whereas Total Current Assets are likely to drop slightly above 29.9 B in 2024.

Technical Drivers

As of the 18th of April 2024, Novartis secures the Mean Deviation of 0.7374, risk adjusted performance of (0.09), and Standard Deviation of 1.03. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG ADR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Novartis, which can be compared to its peers in the industry. Please verify Novartis AG ADR market risk adjusted performance and treynor ratio to decide if Novartis AG ADR is priced some-what accurately, providing market reflects its recent price of 92.57 per share. Given that Novartis AG ADR has information ratio of (0.20), we recommend you to check Novartis's last-minute market performance to make sure the company can sustain itself at a future point.

Novartis AG ADR Price Movement Analysis

Novartis Predictive Daily Indicators

Novartis Corporate Filings

Novartis Forecast Models

Novartis' time-series forecasting models are one of many Novartis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novartis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novartis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novartis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novartis. By using and applying Novartis Stock analysis, traders can create a robust methodology for identifying Novartis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Novartis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Novartis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Novartis AG ADR stock analysis indicators help investors evaluate how Novartis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Novartis shares will generate the highest return on investment. By understating and applying Novartis stock analysis, traders can identify Novartis position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.

Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.